Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: beltramo g. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents.
Beynat-Mouterde C, Beltramo G, Lezmi G, Pernet D, Camus C, Fanton A, Foucher P, Cottin V, Bonniaud P. Beynat-Mouterde C, et al. Among authors: beltramo g. Eur Respir J. 2014 Aug;44(2):523-7. doi: 10.1183/09031936.00214713. Epub 2014 May 2. Eur Respir J. 2014. PMID: 24791830 Free article. No abstract available.
Haemoptysis: a frequent diagnostic challenge.
Bonniaud P, Georges M, Abdulmalak C, Beltramo G, Cottenet J, Camus P, Quantin C. Bonniaud P, et al. Among authors: beltramo g. Eur Respir J. 2016 Jan;47(1):350-1. doi: 10.1183/13993003.01461-2015. Eur Respir J. 2016. PMID: 26721970 Free article. No abstract available.
Pulmonary hypertension associated with ponatinib therapy.
Quilot FM, Georges M, Favrolt N, Beltramo G, Foignot C, Grandvuillemin A, Montani D, Bonniaud P, Camus P. Quilot FM, et al. Among authors: beltramo g. Eur Respir J. 2016 Feb;47(2):676-9. doi: 10.1183/13993003.01110-2015. Epub 2016 Jan 7. Eur Respir J. 2016. PMID: 26743481 Free article. No abstract available.
Pharmacological management of IPF.
Borie R, Justet A, Beltramo G, Manali ED, Pradère P, Spagnolo P, Crestani B. Borie R, et al. Among authors: beltramo g. Respirology. 2016 May;21(4):615-25. doi: 10.1111/resp.12778. Epub 2016 Apr 12. Respirology. 2016. PMID: 27072575 Free article. Review.
Halo Sign and Eosinophilia: What Is Your Diagnosis?
Thevenet F, Beltramo G, Georges M, Foignot C, Spanjaard M, Bonniaud P. Thevenet F, et al. Among authors: beltramo g. Respiration. 2018;95(4):258-259. doi: 10.1159/000485137. Epub 2017 Dec 21. Respiration. 2018. PMID: 29268265 Free article.
98 results